Established in 2006, Eisai has been advancing healthcare in Singapore for nearly two decades. The company, officially Eisai (Singapore) Pte. Ltd. operating under registration number 200607588R, focuses on pharmaceuticals in neurology and oncology. It operates from Gateway East in the Beach Road area. This firm delivers innovative treatments to address unmet medical needs. Furthermore, it emphasizes human health care philosophy. Singapore gains from its global expertise. The team promotes cutting-edge medicines. They aim to improve patient quality of life. Consequently, Eisai supports local health initiatives.
Summary of Its Services/Products
The company offers a range of pharmaceutical products targeting serious conditions. It specializes in neurology treatments like Leqembi for Alzheimer’s disease. Additionally, epilepsy medications include Fycompa and Inovelon. Oncology options feature Halaven for breast cancer. Furthermore, Lenvima addresses thyroid and renal cancers. The firm provides gastrointestinal drugs such as Pariet for ulcers. Insomnia relief comes from Dayvigo. They also supply treatments for multiple sclerosis like Tysabri. This lineup meets diverse healthcare demands. Consequently, patients access advanced therapies through Eisai Pharmaceuticals in Singapore.
Unique Value Propositions or Benefits
It brings global innovations to local patients swiftly. The human health care philosophy prioritizes patient needs. Furthermore, focus on unmet areas like Alzheimer’s offers hope. Teams collaborate internationally for better outcomes. Additionally, sustainable practices ensure long-term impact. This approach enhances treatment efficacy. Healthcare providers value reliable supply. Consequently, Singapore’s medical landscape improves. The company invests in research for future solutions. Overall, these elements provide superior care in Eisai Pharmaceuticals in Singapore.
Any Standout Features or Reviews
The recent approval of Leqembi in 2025 marks a milestone. This drug targets Alzheimer’s progression effectively. Furthermore, the hhc philosophy inspires patient-centered innovation. One intern shared a positive experience with engaging projects. She appreciated good mentorship and a pleasant environment. Another review called it great overall. Additionally, employee ratings average 3.8 stars on Glassdoor. AmbitionBox scores reach 3.9 with strong work-life balance. Consequently, it fosters a supportive culture. These aspects highlight Eisai’s commitment in Singapore.
Areas of Singapore That They Serve
It serves the entire island from its central Beach Road location. The office supports nationwide distribution. Furthermore, partnerships reach hospitals in various districts. This includes central and eastern areas easily. Teams cover western industrial zones too. Additionally, products supply clinics island-wide. The company addresses urban and suburban needs. Consequently, residents everywhere benefit. Singapore’s north and south access treatments seamlessly. Overall, comprehensive coverage ensures broad reach.
How Does the Brand Meet Singapore’s Needs?
The firm tackles rising dementia cases with Leqembi. It aligns with Singapore’s aging population challenges. Furthermore, oncology drugs combat common cancers. This supports national health priorities. Teams focus on innovative solutions. Additionally, global resources aid local adaptations. The company creates jobs in pharmaceuticals. Consequently, it boosts economic growth. Singapore benefits from advanced neurology care. Overall, these contributions enhance public well-being.
Contact Information and Social Media
Visit them at 152 Beach Road, #15-07/08 Gateway East, Singapore 189721. Call +65-6296-6977 or +65-6296-6577 for inquiries. No email is listed publicly. Furthermore, social media links are not available. Check the website for updates. The team handles product information there. Additionally, global channels may offer more. Consequently, connections remain accessible. Explore their innovations online.
Summary
Eisai pioneers pharmaceutical advancements in Singapore, focusing on neurology and oncology to improve lives.
Disclaimer: All information provided here has been compiled from publicly available sources. While we have made every effort to ensure accuracy, we do not guarantee that the information is complete or error-free. We disclaim any liability for inaccuracies or omissions. If you find any errors or have concerns about the content, please let us know so we can address them promptly.
